Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-26T09:48:34.408Z Has data issue: false hasContentIssue false
  • English
  • Français

Role of Horizontal Transfer of the Transposon Tn1546 in the Nosocomial Spread of vanA Vancomycin-Resistant Enterococci at a Tertiary Care Hospital in Korea

Published online by Cambridge University Press:  21 June 2016

Soo Jin Yoo ,
Heungsup Sung ,
Young-Uk Cho ,
Mi-Na Kim ,
Chik Hyun Pai  and
Yang Soo Kim
Soo Jin Yoo
Affiliation:
Departments of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea Department of Laboratory Medicine, Sangye Paik Hospital, Inje University College of Medicine, Seoul, Korea
Heungsup Sung
Affiliation:
Departments of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
Young-Uk Cho
Affiliation:
Departments of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
Mi-Na Kim*
Affiliation:
Departments of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
Chik Hyun Pai
Affiliation:
Departments of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
Yang Soo Kim
Affiliation:
Internal Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
*
Department of Laboratory Medicine, Asan Medical Center, 388-1 Pungnap-dong, Songpa-gu, Seoul, Korea138-736, ([email protected])
Get access Rights & Permissions [Opens in a new window]

Extract

Objective:

To investigate the epidemiologic characteristics of vancomycin-resistant enterococci (VRE) infection.

Design.

An epidemiologic description by means of chromosomal DNA fingerprinting and transposon typing.

Setting.

A 2,200-bed tertiary care hospital in Korea.

Patients.

First VRE isolates were obtained from patients hospitalized from April 1997 to December 2001.

Interventions.

The van genotypes of isolates were identified by means of multiplex polymerase chain reaction (PCR). The macro-restriction patterns of chromosomal DNA were determined by pulsed-field gel electrophoresis (PFGE). The transposon Tn1546was typed by means of 2 sets of long PCR restriction fragment-length polymorphism analysis, which were ClaI restriction of a 10.4-kb region from orf1 to vanZ and DdeI restriction of a 4.4-kb region from vanR to vanX.

Results.

VRE isolates were recovered from 215 patients. All were vanA genotype. PFGE analysis of the 215 isolates showed 172 types, including 21 clusters composed of 64 isolates and 151 types of as many isolates. Each type was composed of 2-10 isolates; the isolates within each PFGE cluster were detected within a 10-month period and mostly shared a transposon type. Transposon typing classified 169 strains into 15 types and 158 strains belonged to 4 major transposon clusters. Each of these 4 transposon clusters was isolated from patients treated in 5-22 different wards during a 31-52 month period and consisted of 9-80 PFGE types. Each of the other 11 types were found in only one strain.

Conclusions.

Our findings suggest that the horizontal transfer of Tn1546 has a major role in the nosocomial spread of vanA VRE. Clonal spread of VRE seemed to contribute to short-term dissemination in limited areas.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 10 , October 2006 , pp. 1081 - 1087
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Leclercq, R, Derlot, E, Duval, J, Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium . N Engl J Med 1988; 319:157–161.Google Scholar
2. Uttley, AH, Collins, CH, Naidoo, J, George, RC. Vancomycin-resistant enterococci. Lancet 1988; 1:57–58.CrossRefGoogle ScholarPubMed
3. Bonten, MJ, Willems, R, Weinstein, RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1:314–325.CrossRefGoogle ScholarPubMed
4. Martone, WJ. Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998; 19:539–545.CrossRefGoogle ScholarPubMed
5. Goossens, H. Spread of vancomycin-resistant enterococci: differences between the United States and Europe. Infect Control Hosp Epidemiol 1998; 19:546–551.CrossRefGoogle ScholarPubMed
6. Bonten, MJ, Hayden, MK, Nathan, C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348:1615–1619.CrossRefGoogle ScholarPubMed
7. Pai, CH, Kim, MN. Antimicrobial resistance in enterococci. Yonsei Med J 1998; 39:554–561.Google Scholar
8. Kim, SJ, Lee, NY, Song, JH, et al. A study on molecular epidemiology of vancomycin-resistant enterococci isolated from hospitals in Korea. Korean J Infect Dis 1998; 30:1–9.Google Scholar
9. Oh, HS, Kim, EC, Oh, MD, Choe, KW. Outbreak of vancomycin resistant enterococcus in a hematology/oncology unit in a Korean University Hospital, and risk factors related to patients, staff, hospital care and facilities. Scand J Infect Dis 2004; 36:790–794.Google Scholar
10. Lee, KW, Kim, MY, Kang, SH, et al. Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli. Yonsei Med J 2003; 44:571–578.CrossRefGoogle ScholarPubMed
11. Yoon, SW, Kim, OS, Peck, KR, et al. Efficacy of infection control strategies for vancomycin-resistant enterococci in a tertiary care hospital. Korean J Infect Dis 2002; 34:81–88.Google Scholar
12. Shin, DH, Park, JH, Shin, JH, Suh, SP, Ryang, DW, Kim, SJ. A molecular epidemiologic study on vancomycin-resistant enterococci isolated from clinical specimens over a 5-year Period. Korean J Infect Dis 2000; 32:203–211.Google Scholar
13. Lee, WG, Jernigan, JA, Rasheed, JK, Anderson, GJ, Tenover, FC. Possible horizontal transfer of the vanB2 gene among genetically diverse strains of vancomycin-resistant Enterococcus faecium in a Korean hospital. J Clin Microbiol 2001; 39:1165–1168.CrossRefGoogle Scholar
14. Morris, JG Jr, Shay, DK, Hebden, JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995; 123:250–259.Google Scholar
15. Kawalec, M, Gniadkowski, M, Hryniewicz, W. Outbreak of vancomycin-resistant enterococci in a hospital in Gdask, Poland, due to horizontal transfer of different Tn1546-like transposon variants and clonal spread of several strains. J Clin Microbiol 2000; 38:3317–3322.Google Scholar
16. Simonsen, GS, Haaheim, H, Dahl, KH, et al. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms. Microb Drug Resist 1998; 4:313–318.CrossRefGoogle ScholarPubMed
17. Song, JY, Hwang, IS, Eom, JS, et al. Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean J Intern Med 2005; 20:55–62.Google Scholar
18. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically. 5th ed. Approved standard M7-A5. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.Google Scholar
19. Clark, NC, Cooksey, RC, Hill, BC, Swenson, JM, Tenover, FC. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993; 37:2311–2317.Google Scholar
20. Arthur, M, Molinas, C, Depardieu, F, Courvalin, P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175:117–127.Google Scholar
21. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128–140. Erratum in: Am J Infect Control 1988; 16:177.CrossRefGoogle ScholarPubMed
22. Murray, BE, Singh, KV, Heath, JD, Sharma, BR, Weinstock, GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990; 28:2059–2063. Erratum in: J Clin Microbiol 1991; 29:418.CrossRefGoogle ScholarPubMed
23. Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233–2239.Google Scholar
24. Haaheim, H, Dahl, KH, Simonsen, GS, Olsvik, O, Sundsfjord, A. Long PCRs of transposons in the structural analysis of genes encoding acquired glycopeptide resistance in enterococci. Biotechniques 1998; 24:432–437.CrossRefGoogle ScholarPubMed
25. Palepou, MF, Adebiyi, AM, Tremlett, CH, Jensen, LB, Woodford, N. Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci. J Antimicrob Chemother 1998; 42:605–612.Google Scholar
26. Descheemaeker, P, Ieven, M, Chapelle, S, et al. Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. J Infect Dis 2000; 181:235–241.Google Scholar
27. Schouten, MA, Willems, RJ, Kraak, WA, Top, J, Hoogkamp-Korstanje, JA, Voss, A. Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering. Antimicrob Agents Chemother 2001; 45:986–989.Google Scholar
28. Scagnelli, M, Pellizer, G, de Lalla, F, et al. Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary-care hospital in Northern Italy. Eur J Clin Microbiol Infect Dis 2001; 20:609–616.Google Scholar
29. Kim, WJ, Weinstein, RA, Hayden, MK. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 1999; 179:163–171.Google Scholar
30. Bonten, MJ, Slaughter, S, Hayden, MK, Nathan, C, van Voorhis, J, Weinstein, RA. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med 1998; 26:2001–2004.Google Scholar
31. de Lencastre, H, Brown, AE, Chung, M, Armstrong, D, Tomasz, A. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital. Microb Drug Resist 1999; 5:113–129.CrossRefGoogle ScholarPubMed
32. Yu, HS, Seol, SY, Cho, DT. Diversity of Tn1546-like elements in vancomycin-resistant enterococci isolated from humans and poultry in Korea. /J Clin Microbiol 2003; 41:2641–2643.Google Scholar
33. Huh, JY, Lee, WG, Lee, K, Shin, WS, Yoo, JH. Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. J Clin Microbiol 2004; 42:1897–1902.Google Scholar
34. Bates, J, Jordens, Z, Selkon, JB. Evidence for an animal origin of vancomycin-resistant enterococci. Lancet 1993; 342:490–491.Google Scholar
35. Torres, C, Tenorio, C, Portillo, A, et al. Intestinal colonization by vanA-or vanB2-containing enterococcal isolates of healthy animals in Spain. Microb Drug Resist 2003; 9(Suppl 1):S47–S52.Google Scholar
36. Willems, RJ, Top, J, van den Braak, N, et al. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 1999; 43:483–491.CrossRefGoogle ScholarPubMed
37. Willems, RJ, Top, J, van Santen, M, et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11:821–828.CrossRefGoogle ScholarPubMed
38. Darini, AL, Palepou, MF, Woodford, N. Effects of the movement of insertion sequences on the structure of VanA glycopeptide resistance elements in Enterococcus faecium . Antimicrob Agents Chemother 2000; 44:1362–1364.Google Scholar